Medicare Enrolled

Dr. Mary Beth Harr, M.D.

Family Medicine · San Antonio, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
7950 FLOYD CURL DR, San Antonio, TX 78229
2106141112
In practice since 2006 (19 years)
NPI: 1043372055 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Harr from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Harr? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Harr

Dr. Mary Beth Harr is a family medicine specialist in San Antonio, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Harr performed 1,365 Medicare services across 978 unique beneficiaries.

Between the years covered by Open Payments, Dr. Harr received a total of $9,751 from 55 pharmaceutical and/or device companies across 608 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Harr is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 21% volume in TX $9,751 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,365
Medicare services
Top 21% in TX for family medicine
978
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~72 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 624 $79 $204
Annual wellness visit, follow-up 248 $124 $211
Annual depression screening 167 $18 $33
Office visit, established patient (20-29 min) 153 $53 $134
Automated urinalysis 83 $2 $30
Urine microalbumin (protein) analysis 25 $6 $25
Electrocardiogram (EKG), 12-lead 22 $7 $75
Drug injection, under skin or into muscle 22 $9 $45
Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment 21 $158 $298
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,751
Total received (2018-2024)
Avg $1,393/year across 7 years
Top 5% in TX for family medicine
55
Companies
608
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,574 (98.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$178 (1.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,387
2023
$1,506
2022
$1,233
2021
$1,648
2020
$1,457
2019
$1,481
2018
$1,039

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,111
Amarin Pharma Inc.
$659
Lilly USA, LLC
$589
Takeda Pharmaceuticals U.S.A., Inc.
$550
AstraZeneca Pharmaceuticals LP
$507
Boehringer Ingelheim Pharmaceuticals, Inc.
$431
Novo Nordisk Inc
$427
PFIZER INC.
$383
Allergan, Inc.
$375
Endo Pharmaceuticals Inc.
$373
Amgen Inc.
$354
Allergan Inc.
$338
AbbVie Inc.
$332
Bayer Healthcare Pharmaceuticals Inc.
$241
Teva Pharmaceuticals USA, Inc.
$217
Janssen Pharmaceuticals, Inc
$185
Astellas Pharma US Inc
$184
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$177
Abbott Laboratories
$172
Paratek Pharmaceuticals, Inc.
$141
SANOFI-AVENTIS U.S. LLC
$136
Esperion Therapeutics, Inc.
$133
Merck Sharp & Dohme Corporation
$126
Shire North American Group Inc
$121
GlaxoSmithKline, LLC.
$117
Avanir Pharmaceuticals, Inc.
$116
Axsome Therapeutics, Inc.
$100
Horizon Therapeutics plc
$92
Biohaven Pharmaceuticals, Inc.
$82
Eisai Inc.
$79
Exact Sciences Corporation
$75
IDORSIA PHARMACEUTICALS US INC
$70
Genentech USA, Inc.
$65
Lundbeck LLC
$61
Corium, LLC
$59
Shield Therapeutics Inc
$55
Supernus Pharmaceuticals, Inc.
$54
Nevro Corp.
$46
Novartis Pharmaceuticals Corporation
$45
Atland Pharmaceuticals, LLC
$40
Currax Pharmaceuticals LLC
$38
Merck Sharp & Dohme LLC
$37
Egalet US Inc
$36
Bausch Health US, LLC
$35
Biohaven Pharmaceutical Holding Company Ltd.
$31
VistaPharm, Inc.
$27
Azurity Pharmaceuticals, Inc.
$19
Gilead Sciences, Inc.
$18
Nalpropion Pharmaceuticals, Inc.
$16
Alfasigma USA, Inc.
$15
Nalpropion Pharmaceuticals LLC
$14
Dexcom, Inc.
$14
Arbor Pharmaceuticals, Inc.
$13
Kowa Pharmaceuticals America, Inc.
$13
AMAG Pharmaceuticals, Inc.
$12
Top 3 companies account for 24.2% of total payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · AJOVY · APLENZIN · AREXVY · ASPIRIN AND CAFFEINE · AZSTARYS · Aimovig · Auvelity · Azstarys · BELSOMRA · BREZTRI · BREZTRI AEROSPHERE · BYSTOLIC · CHANTIX · COLOGUARD · CONTRAVE · Cologuard Collection Kit · DEXCOM G6 CGM SYSTEM · Dayvigo · Descovy · EMGALITY · ENTRESTO · EVENITY · Edarbi · FARXIGA · GARDASIL · GARDASIL 9 · INTRAROSA · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · LO LOESTRIN FE · LYRICA · Livalo · MOUNJARO · MYDAYIS · NASCOBAL · NEXLETOL · NEXLIZET · NUEDEXTA · NURTEC ODT · NUZYRA · Neuromodulation Dspsbls and Accs · OCTRODE · ORPHENADRINE CITRATE · Omnia · Otezla · Ozempic · PAXLOVID · PENNSAID · PNEUMOVAX 23 · PREMARIN · PREVNAR 13 · PREVNAR 20 · QELBREE · QULIPTA · QUVIVIQ · Qelbree · REXULTI · Repatha · Rybelsus · SHINGRIX · SOLIQUA 100/33 · SPRIX · STEGLUJAN · SYMBICORT · SYNTHROID · Saxenda · Senza · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · Thyquidity · Trintellix · UBRELVY · VIBERZI · VIIBRYD · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · WELLBUTRIN · Wegovy · XARELTO · XIFAXAN · Xofluza
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for family medicine in TX.

Equivalent to $714 per 100 Medicare services performed
Looking for a family medicine specialist in San Antonio?
Compare family medicine physicians in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
948
Per 100K population
46.5
County median income
$70,571
Nearest hospital
UNIVERSITY HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Harr is a clinical cardiology specialist, with above-average Medicare volume (top 21% in TX), with low-engagement industry engagement in the top 5% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Harr experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Harr performed 624 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Harr receive payments from pharmaceutical companies?
Yes. Dr. Harr received a total of $9,751 from 55 companies across 608 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Harr's costs compare to other family medicine physicians in San Antonio?
Dr. Harr's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Harr) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →